Domestic pharmaceutical companies are rapidly moving into the fast-growing market for weight-loss drugs, following the expiry of a key patent. The shift comes after the patent on semaglutide, the ...

GLP-1 drugs like semaglutide (Ozempic and Wegovy) have finally started to make weight loss a sustainable reality for many people with obesity. The ceiling of obesity treatment hasn’t been reached yet, ...

A strawweight unification bout is no longer in play but the fallout could benefit another match-up already on the schedule. Siyakholwa Kuse and Joey Canoy are slated to meet in a WBC 105lbs title ...

A bold new ready-to-drink coffee brand brings smooth nitro energy and modern flavors direct to consumers nationwide. ATLANTA, Feb. 3, 2026 /PRNewswire/ -- Coffee culture is evolving beyond the basic ...

PDF readers and open-source libraries used in document processing will all need updating to handle the Brotli compression filter. Brotli is one of the most widely used but least-known compression ...

Add Yahoo as a preferred source to see more of our stories on Google. Wegovy pens are sorted at a packaging line at Novo Nordisk's facility in Hillerod, Denmark, March 8, 2024. REUTERS/Tom Little Dec ...

Wegovy pens are sorted at a packaging line at Novo Nordisk's facility in Hillerod, Denmark, March 8, 2024. REUTERS/Tom Little Dec 23 (Reuters) - The weight-loss drug market is surging, with biotech ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

One evening, my wife and I stumbled upon Fit for TV: The Reality of the Biggest Loser, a documentary that pulled back the curtain on the reality show that turned weight loss into a televised ...

Fintel reports that on December 17, 2025, Morgan Stanley maintained coverage of Lineage (NasdaqGS:LINE) with a Equal-Weight recommendation. As of December 6, 2025, the average one-year price target ...

Fintel reports that on November 25, 2025, Wells Fargo maintained coverage of Lineage (NasdaqGS:LINE) with a Equal-Weight recommendation. As of November 17, 2025, the average one-year price target for ...